Pseudomonas aeruginosa is an opportunistic pathogen displaying high intrinsic
antimicrobial resistance and the ability to thrive in different ecological environments. In this …

Objectives To determine the susceptibility profiles and the resistome of Pseudomonas
aeruginosa isolates from European ICUs during a prospective cohort study (ASPIRE-ICU) …

Carbapenem antibiotics constitute the mainstay therapy of nosocomial infections with
extended spectrum beta-lactamase producing Gram-negative bacteria; however, resistance …

Background Pseudomonas aeruginosa healthcare-associated infections are one of the top
antimicrobial resistance threats world-wide. In order to analyze the current trends, we …

In contrast to the many reports of successful real-world cases of personalized bacteriophage
therapy (BT), randomized controlled trials of non-personalized bacteriophage products have …

Pseudomonas aeruginosa is a major opportunistic pathogen and one of the leading
bacterial species causing health care-associated infections. Carbapenems are the most …

Antimicrobial resistance (AMR) has become a global medical priority that needs urgent
resolution. Pseudomonas aeruginosa is a versatile, adaptable bacterial species with …

Purpose Pseudomonas aeruginosa is an important pathogen that causes urinary tract
infections. Carbapenems are the drugs of choice for the treatment of P. aeruginosa …

The high use of antibiotics in human and veterinary medicine has led to a wide spread of
antibiotics and antimicrobial resistance into the environment. In recent years, various studies …

Increasing isolation rates of resistant bacteria in the last years require identification of
potential infection reservoirs in healthcare facilities. Especially the clinical wastewater …